BLH4 Antibody

Shipped with Ice Packs
In Stock

Description

Search Scope and Methodology

The search included peer-reviewed articles, technical databases (e.g., PubMed Central, Antibody Society), and commercial antibody catalogs. Key terms such as "BLH4," "BLH4 Antibody," and associated synonyms yielded no matches across the nine provided sources.

Terminology Mismatch

  • The term "BLH4" does not align with established antibody nomenclature (e.g., IgG, IgM) or target antigens (e.g., CD20, HER2) in immunology literature .

  • Closest matches include BLyS (B lymphocyte stimulator) and APRIL (A Proliferation Inducing Ligand) antibodies, which modulate B-cell activity in autoimmune diseases .

Typographical Error

  • If the query refers to BLyS/BAFF or APRIL antibodies, extensive data exists on their roles in conditions like multiple sclerosis . For example:

    Antibody TargetFunctionClinical Application
    Anti-BLyS (e.g., Belimumab)Depletes CD20+ B cells, reduces autoantibodiesSystemic lupus erythematosus (SLE), EAE models
    Anti-APRILAttenuates T-cell activation, delays demyelinationPreclinical MS models

Emerging or Obscure Targets

  • No antibodies targeting "BLH4" are listed in the Antibody Society’s database of approved or investigational therapeutics .

Recommendations for Further Research

If "BLH4" is a novel or proprietary target, consider:

  1. Validating the term with public antibody databases (e.g., UniProt).

  2. Reviewing patent filings or preprints for unpublished data.

  3. Confirming the target’s biological pathway or structure (e.g., is it a cytokine, receptor, or enzyme?).

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
BLH4 antibody; SAW2 antibody; At2g23760 antibody; F27L4.6BEL1-like homeodomain protein 4 antibody; BEL1-like protein 4 antibody; Protein SAWTOOTH 2 antibody
Target Names
BLH4
Uniprot No.

Target Background

Function
BLH4 is a transcription factor that plays a crucial role in establishing leaf shape by inhibiting growth in specific regions of the leaf. It negatively regulates the expression of the knox homeobox gene KNAT1/BP, which is involved in leaf development.
Gene References Into Functions
  1. Research indicates that BLH2/SAW1 and BLH4/SAW2 contribute to leaf shape formation by suppressing growth in specific leaf subdomains. This suppression is achieved, at least in part, by repressing the expression of one or more KNOX genes. [SAW2] PMID: 17873098
Database Links

KEGG: ath:AT2G23760

STRING: 3702.AT2G23760.1

UniGene: At.12624

Protein Families
TALE/BELL homeobox family
Subcellular Location
Nucleus.
Tissue Specificity
Expressed in lateral organs.

Q&A

What is BLH4 and what cellular role does it play in plants?

BLH4 is a transcription factor that, together with BLH2, regulates de-methylesterification of homogalacturonan (HG) in seed mucilage by directly activating PME58. Both BLH2 and BLH4 are expressed in mucilage secretory cells (MSCs) during mucilage production, with expression patterns that are almost identical. Research has shown that BLH4 expression increases during seed development, with relatively weak signals detected at 4-7 days post anthesis (DPA), more intense signals at 10 DPA, and strong hybridization signals in the cytoplasm and columella of MSCs by 13 DPA .

What are the primary applications of BLH4 antibodies in plant molecular biology research?

BLH4 antibodies serve several critical functions in research:

  • Protein expression analysis: Western blotting to detect BLH4 protein levels during development.

  • Chromatin immunoprecipitation (ChIP): Identifying genomic regions where BLH4 binds, such as the PME58 promoter.

  • Immunolocalization: Determining subcellular localization of BLH4 protein and comparing with in situ hybridization data.

  • Co-immunoprecipitation: Investigating protein-protein interactions with potential partners.

  • Functional validation: Confirming BLH4's role in activating downstream targets involved in mucilage production.

How can researchers validate the specificity of BLH4 antibodies?

Antibody validation is critical for reliable research. For BLH4 antibodies, comprehensive validation should include:

Validation TechniqueMethodologyExpected Results for Specific Antibody
Western blotCompare wild-type vs. blh4 mutantsAbsence of specific band in mutant
ImmunohistochemistryCompare wild-type vs. blh4 mutantsLoss of signal in mutant tissues
Peptide competitionPre-absorption with immunizing peptideElimination of specific signal
Double mutant testingTest in blh2 blh4 double mutantsComplete absence of signal
Overexpression linesTest in BLH4 overexpression plantsEnhanced signal intensity

Since BLH2 and BLH4 function redundantly in regulating PME58 activation, using blh2 blh4 double mutants as negative controls can provide additional validation by eliminating concerns about compensatory expression .

What developmental stages are critical when studying BLH4 expression in seeds?

Based on research findings, BLH4 expression follows a specific temporal pattern during seed development:

  • 4-7 DPA: Initial expression with relatively weak signals

  • 10 DPA: Increased expression with more intense signals

  • 13 DPA: Peak expression with strong signals in cytoplasm and columella

For comprehensive analysis, researchers should include samples from each of these key developmental stages. The most pronounced expression appears at 13 DPA, making this a particularly important timepoint for antibody-based detection methods .

How should experimental controls be designed for BLH4 antibody applications?

Proper experimental controls are essential for reliable interpretation of results:

Positive controls:

  • Wild-type plant tissues at 13 DPA (peak expression)

  • BLH4 overexpression lines

  • Recombinant BLH4 protein (if available)

Negative controls:

  • blh4 single mutants (partial reduction expected due to redundancy)

  • blh2 blh4 double mutants (complete absence of function)

  • Pre-immune serum controls

  • Secondary antibody-only controls

Technical controls:

  • Loading controls for Western blots (actin, tubulin)

  • Internal reference tissues with known expression patterns

What considerations should be made when designing ChIP experiments with BLH4 antibodies?

ChIP experiments to identify BLH4 target genes require careful planning:

  • Chromatin preparation: Optimize crosslinking time for plant tissues (typically 10-15 minutes with formaldehyde)

  • Sonication conditions: Adjust to achieve 200-500bp DNA fragments

  • Antibody selection: Use ChIP-validated BLH4 antibodies

  • Positive controls: Include primers for known BLH4 targets such as PME58 promoter regions

  • Negative controls: Include primers for non-target regions and perform ChIP with non-specific IgG

Research has demonstrated that BLH2 and BLH4 directly activate PME58, making the PME58 promoter an excellent positive control for ChIP experiments .

How can BLH4 antibodies be used to investigate the molecular mechanism of PME58 activation?

BLH4 antibodies can help elucidate the precise mechanism by which BLH4 activates PME58, which is critical for seed mucilage formation:

  • ChIP-seq analysis: Identify the exact binding sites of BLH4 in the PME58 promoter

  • Sequential ChIP (ChIP-reChIP): Determine if BLH2 and BLH4 bind simultaneously as a complex

  • Promoter dissection: Combined with reporter gene assays to identify critical regulatory elements

  • Protein complex identification: Immunoprecipitate BLH4 to identify co-factors involved in PME58 activation

Research has already established that BLH2 and BLH4 redundantly regulate de-methylesterification of HG in seed mucilage by directly activating PME58, as demonstrated by the mucilage adherence defects in blh2 blh4 mutants that could be rescued by PME58 overexpression .

How can researchers utilize BLH4 antibodies to study protein-protein interactions?

Understanding protein-protein interactions is crucial for deciphering transcription factor function:

  • Co-immunoprecipitation: Use BLH4 antibodies to pull down protein complexes, followed by mass spectrometry or Western blotting to identify interaction partners

  • Proximity ligation assay (PLA): Detect in situ protein-protein interactions with single-molecule sensitivity

  • FRET/FLIM analysis: When combined with fluorescently-tagged proteins, can reveal direct interactions

  • Yeast two-hybrid validation: Confirm interactions identified through antibody-based methods

Given the functional redundancy between BLH2 and BLH4, investigating potential heterodimerization or complex formation between these two transcription factors would be particularly informative .

What approaches can be used to study BLH4 in relation to other transcription factors in the regulatory network?

To place BLH4 within its broader regulatory context:

  • Comparative ChIP-seq: Analyze binding site overlap between BLH4 and other transcription factors

  • Sequential ChIP: Determine co-occupancy of genomic regions

  • Transcriptome analysis: Compare gene expression changes in blh4 mutants vs. other transcription factor mutants

  • Protein-protein interaction network mapping: Using BLH4 antibodies as entry points for complex purification

This approach could help identify whether BLH4 functions as part of a larger transcriptional complex that regulates multiple aspects of seed development beyond PME58 activation.

What tissue preparation methods work best for BLH4 immunolocalization in seed tissues?

Optimal tissue preparation is critical for successful immunolocalization:

Preparation StepRecommended MethodRationale
Fixation4% paraformaldehyde, 16-24 hoursPreserves protein epitopes while maintaining tissue integrity
EmbeddingParaffin or LR White resinParaffin for general localization; resin for higher resolution
Sectioning5-8 μm thick sectionsThin enough for good resolution of MSCs
Antigen retrievalCitrate buffer (pH 6.0), heat-mediatedUnmasks epitopes that may be cross-linked during fixation
Blocking5% BSA or normal serumReduces non-specific binding

Since BLH4 shows distinct expression patterns in MSCs at different developmental stages, optimizing tissue preparation is essential for accurately capturing this temporal and spatial expression pattern .

How can researchers optimize Western blotting protocols for BLH4 detection?

Western blotting for plant transcription factors like BLH4 requires specific considerations:

  • Protein extraction: Use nuclear extraction protocols to enrich for transcription factors

  • Sample preparation: Include protease inhibitors and phosphatase inhibitors to prevent degradation

  • Gel concentration: Use 10-12% polyacrylamide gels for optimal resolution

  • Transfer conditions: Optimize transfer time and voltage for proteins in the expected size range

  • Blocking: Use 5% non-fat dry milk or BSA to reduce background

  • Antibody dilution: Typically start with 1:1000 dilution and adjust as needed

  • Detection method: Enhanced chemiluminescence or fluorescent detection systems

Due to the typically low abundance of transcription factors like BLH4, sample enrichment and sensitive detection methods are particularly important.

How should researchers approach dual labeling experiments with BLH4 antibodies and in situ hybridization?

Combining protein and mRNA detection provides comprehensive insight into BLH4 expression:

  • Sequential processing:

    • Perform in situ hybridization first, document results

    • Follow with immunodetection on the same sections

    • Use different chromogens or fluorophores for each target

  • Controls for dual labeling:

    • Single-labeling controls for each detection method

    • Sense probe controls for in situ hybridization

    • Secondary antibody-only controls for immunodetection

  • Analysis approaches:

    • Co-localization analysis for fluorescent detection

    • Quantitative comparison of signal intensities

    • Temporal correlation between mRNA and protein expression

This approach can reveal potential post-transcriptional regulation by identifying any discrepancies between BLH4 transcript localization (detected by in situ hybridization) and protein localization (detected by immunohistochemistry) .

How should researchers quantify and statistically analyze BLH4 immunolocalization data?

Quantitative analysis of immunolocalization requires systematic approaches:

  • Image acquisition: Standardize exposure times and imaging parameters across all samples

  • Signal quantification: Measure fluorescence intensity or DAB staining using image analysis software

  • Cell-specific analysis: Quantify signal specifically within MSCs at each developmental stage

  • Statistical approach:

    • Minimum of 3 biological replicates

    • Analysis of multiple cell measurements per sample

    • ANOVA for comparing multiple developmental stages

    • Appropriate post-hoc tests for specific comparisons

  • Data presentation: Include both representative images and quantitative graphs with error bars

This approach allows for rigorous quantitative assessment of BLH4 expression patterns across development and in different genetic backgrounds.

What are the best approaches for analyzing ChIP-seq data for BLH4 binding sites?

ChIP-seq analysis for transcription factors like BLH4 requires specialized bioinformatic approaches:

  • Peak calling: Use algorithms optimized for transcription factor binding (e.g., MACS2)

  • Motif discovery: Identify DNA sequence motifs enriched in BLH4-bound regions

  • Target gene assignment: Map binding sites to nearest genes or regulatory elements

  • Functional annotation: Perform GO term and pathway enrichment analysis of target genes

  • Integration with expression data: Correlate binding sites with gene expression changes in blh4 mutants

  • Visualization: Create genome browser tracks showing BLH4 binding in relation to gene models

This approach can help identify the full complement of genes directly regulated by BLH4, beyond the known target PME58 .

How can researchers distinguish between direct and indirect effects when studying BLH4 function with antibodies?

Distinguishing direct from indirect effects requires combining multiple approaches:

  • ChIP-seq + RNA-seq integration: Identify genes both bound by BLH4 and differentially expressed in blh4 mutants

  • Time-course experiments: Determine the temporal sequence of molecular events following BLH4 activation

  • Inducible systems: Use inducible BLH4 expression systems combined with transcriptional inhibitors

  • Motif analysis: Identify BLH4 binding motifs in promoters of putative direct targets

  • Reporter gene assays: Validate direct transcriptional activation by BLH4

For example, research has shown that PME58 is a direct target of BLH4 through multiple lines of evidence: reduced expression in blh4 mutants, rescue of the mutant phenotype by PME58 overexpression, and no additional defects in blh2 blh4 pme58 triple mutants compared to blh2 blh4 double mutants .

What are common challenges when working with plant transcription factor antibodies like BLH4?

Researchers should be prepared to address several common challenges:

ChallengePotential CausesTroubleshooting Approaches
Low signal intensityLow protein abundance, epitope inaccessibilityIncrease antibody concentration, optimize antigen retrieval
High backgroundNon-specific binding, inadequate blockingIncrease blocking time/concentration, pre-absorb antibody
Cross-reactivitySimilarity with BLH2, other family membersUse peptide-specific antibodies, validate with mutants
Inconsistent resultsProtocol variability, antibody qualityStandardize protocols, test antibody lots for consistency
Poor nuclear signalInsufficient nuclear permeabilizationIncrease detergent concentration, optimize fixation

The functional redundancy between BLH2 and BLH4 makes cross-reactivity a particular concern that requires careful validation with appropriate genetic controls .

How can researchers verify that their BLH4 antibody is detecting the correct protein in complex samples?

Verification strategies to ensure antibody specificity include:

  • Genetic approaches:

    • Test in blh4 single mutants (expect reduced signal)

    • Test in blh2 blh4 double mutants (expect absence of signal)

    • Test in BLH4 overexpression lines (expect enhanced signal)

  • Biochemical approaches:

    • Mass spectrometry identification of immunoprecipitated proteins

    • Peptide competition assays

    • Antibody validation using recombinant BLH4 protein

  • Combined approaches:

    • Parallel analysis with multiple antibodies against different epitopes

    • Correlation with fluorescent protein fusion localization patterns

    • Functional rescue experiments combined with immunodetection

These approaches are particularly important when studying proteins like BLH4 that have close homologs (such as BLH2) with similar expression patterns and functions .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.